GENE ONLINE|News &
Opinion
Blog

2025-02-25|

Revolutionary AI Tool Identifies Overlooked Brain Abnormalities in Epileptic Children

by Mark Chiang
Share To
Newsflash | Powered by GeneOnline AI

Scientists have made a significant breakthrough in the diagnosis of epilepsy in children by developing an artificial intelligence (AI) tool capable of detecting brain abnormalities that are often missed by human radiologists. This innovative technology has successfully identified 64% more brain abnormalities linked to epilepsy, which typically remain invisible in standard diagnostic procedures.

The development of this AI tool marks a crucial advancement in pediatric neurology, providing new avenues for early and more accurate diagnosis and treatment of epilepsy among children. The findings underscore the potential of AI to enhance medical imaging techniques and improve patient outcomes significantly.

Date: February 24, 2025

Newsflash | Powered by GeneOnline AI

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
AI’s Promise to Profits: How IBM is Maximizing Business ROI with Accelerated Computing
2025-03-19
Edge Computing: The Next Big Thing in AI and Automation
2025-03-19
Neurosurgery Now: NVIDIA’s Holoscan AI Brings Real-Time 3D Vision to Enhance Surgical Precision at 2025 GTC
2025-03-18
NVIDIA GTC 2025: BioMap’s xTrimo — The AI Model That’s Changing Biotech and Drug Discovery
2025-03-18
AstraZeneca Acquires Cell Therapy Company in $1 Billion Deal to Develop In Vivo Cancer Treatments
2025-03-18
Gene Therapy Achieves Complete Cure for Sickle Cell Anemia in New York Patient
2025-03-17
NICE Recommends New Endometriosis Treatment for NHS Patients
2025-03-14
EVENT
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
Scroll to Top